First American Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,207
Closed -$563K 140
2018
Q2
$563K Hold
5,207
0.13% 89
2018
Q1
$551K Buy
5,207
+12
+0.2% +$1.39K 0.13% 89
2017
Q4
$609K Hold
5,195
0.15% 82
2017
Q3
$591K Hold
5,195
0.15% 78
2017
Q2
$648K Hold
5,195
0.18% 80
2017
Q1
$616K Sell
5,195
-8
-0.2% -$907 0.19% 78
2016
Q4
$521K Buy
5,203
+8
+0.2% +$857 0.16% 80
2016
Q3
$656K Hold
5,195
0.2% 77
2016
Q2
$607K Hold
5,195
0.21% 78
2016
Q1
$538K Buy
5,195
+309
+6% +$29.9K 0.19% 78
2015
Q4
$487K Hold
4,886
0.18% 81
2015
Q3
$446K Buy
+4,886
New +$490K 0.17% 80
2014
Q2
Sell
-6,170
Closed -$567K 93
2014
Q1
$567K Hold
6,170
0.21% 71
2013
Q4
$558K Hold
6,170
0.19% 80
2013
Q3
$492K Buy
+6,170
New +$486K 0.18% 80

Other funds holding ZBH

First American Trust's ZBH Position: Q3 2018 in Review

First American Trust sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 5,207 shares — an estimated $563K sold.

First American Trust first reported a position in ZBH in Q3 2013 and held it in 15 quarters. The position peaked at $656K in Q3 2016. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • First American Trust reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • First American Trust sold 5,207 Zimmer Biomet shares in Q3 2018, an estimated $563K.
  • First American Trust first reported a position in Zimmer Biomet in Q3 2013 and held it in 15 quarters.
  • First American Trust's Zimmer Biomet position peaked at $656K in Q3 2016.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on First American Trust's 13F filing for Q3 2018, filed 3 Oct 2018.